Page 9 - Veena Mani

Vision of Pandit Upadhyaya will reflect in next Budget: Arjun Meghwal

While Budget 2017 will be firmly 'pro poor', there will be no populist vote-bank measures

Access to medicines a problem in India: Annaswamy Vaideesh, GSK India MD

Vaideesh says that the real problem is not capping of drug prices, but in the method adopted in revising prices

Standard Chartered chairman Sir John Peace favours internationalisation of rupee

His comments came at a time when masala bond has come up as an instruments to attract international investment

Cartelisation probe against Dr Reddy's, Sun Pharma in US

Pharma stocks tumble 4% on BSE; Sun Pharma down 7.4%, Dr Reddy's loses 5.6%

Expert panel recommends expanding NPPA's mandate

At present, the NPPA monitors drugs that are part of NLEM and identifies players that overcharge

Health ministry wants govt to exit tobacco firms

The appeal is against the backdrop of criticism from NGOs and activists that the govt has been heavily investing in ITC

Regulator should fix prices for drugs not in essential list too: Panel

At present, the NPPA monitors drugs which are part of the National List of Essential Medicines

Strides Shasun plans listing of biotech arm

Earlier this year, the biotech arm raised $8.49 million from GMS Holdings, a Jordan-based investment entity

Government to consider extending shelf life of medical device after interim assessment of performance

The government has suggested a five year blanket on shelf life of all medical devices in the draft released on 19th Oct

Drug companies step up global investments to tap biosimilars

Cipla is investing Rs 600 crore to set up a manufacturing plant for biosimilars in South Africa

CCI gives nod to Fortis, Sun Pharma deals

The body also said it had approved the proposed restructuring of Fortis Group

Pharma companies increase investments for global biosimilar push

Biosimilars are made from living cells and are far more complex and expensive to manufacture than generic drugs

Govt to give a fresh push to Jan Aushadhi Scheme, plans to increase store count

Ministry of Chemicals and Fertilizers is trying to rope in MPs to open new stores in their constituencies

CCI to probe GAIL for alleged unfair biz practices

The watchdog called for a detailed probe after clubbing five complaints which alleged unfair business practices

Sun enters vaccine space with dengue shot

This is the second tie-up between the International Centre for Genetic Engineering and Biotechnology and Sun Pharmaceuticals

Medical devices regulation 2.0 draws industry's ire

The new draft wants companies to specify manufacturing date along with expiry date on packaging

PM's new health insurance scheme may cost over Rs 8000 crore

Currently, the poor families are covered under Rashtriya Swasthya Bima Yojana for up to Rs 30,000 expenses

Initiate suitable prosecution steps against AstraZeneca management, pleads FMRI

The company recently terminated 50 employees

NYSE listed Aetna enters Indian market with IHO

Aetna has invested Rs 100 Crores for its maiden venture in India

'Sustained funding is difficult to get in India': Davinder Gill

Interview of CEO of Hilleman Laboratories, Davinder Gill